Last updated: July 27, 2025
Introduction
Patent KR20170008252, filed in South Korea, represents a noteworthy intellectual property asset within the pharmaceutical sector. This patent, issued or pending, delineates specific claims around a novel drug or therapeutic composition, potentially offering competitive advantages in its targeted therapeutic area. This analysis explores the scope and claims of KR20170008252, evaluates its position within the broader patent landscape, and considers strategic implications for stakeholders.
Patent Overview and Filing Details
While detailed metadata for KR20170008252 requires access to the Korean Intellectual Property Office (KIPO), typically, such patents are filed to protect novel compounds, formulations, or therapeutic methods. Based on available patent document structures and industry standards, the patent likely relates to a novel chemical entity, a specific pharmaceutical composition, or a method of treatment.
Filing Timeline and Status:
- Filing date: Likely in early 2017, given the serial number.
- Publication date: Usually within 18 months of filing, confirming public accessibility.
- Grant status: Pending or granted, depending on review progress.
Scope of the Patent
Scope Definition:
The scope establishes the boundaries of the patent rights, generally articulated through broad claims followed by narrower dependent claims. The scope in KR20170008252 is presumed to target:
- Chemical or biological compounds with specific structural features.
- Pharmaceutical compositions comprising the claimed compounds and excipients.
- Therapeutic methods involving administration of these compositions for particular indications, such as oncology, neurology, or infectious diseases.
Key Elements of the Scope:
- Chemical Structure and Variations: Likely includes claims around core molecules with particular substitutions, stereochemistry, or salt forms.
- Manufacturing Processes: Claims may cover synthesis routes, purification steps, or formulation techniques.
- Use and Method Claims: Encompassing therapeutic applications, dosage regimens, and routes of administration.
The precise breadth of claims defines how strong the patent is in precluding competitors from developing similar drugs or formulations.
Claims Analysis
1. Independent Claims:
Typically, the independent claims set the foundation, emphasizing the novel chemical compound or therapeutic method. For KR20170008252, these likely specify:
- A chemical compound with certain structural characteristics.
- A pharmaceutical composition incorporating the compound.
- A method of treatment using the composition for a specific condition.
2. Dependent Claims:
Dependent claims narrow the scope, adding specific features such as:
- Pharmacokinetic properties (e.g., increased bioavailability).
- Specific dosage forms (e.g., tablets, injectables).
- Combination therapies with existing drugs.
- Particular indications or patient populations.
3. Claim Scope Implications:
Broader claims enhance patent strength but risk validity issues if similar prior art exists. Narrower claims offer precision but can limit market exclusivity.
Patent Landscape Analysis
1. Patent Family and Priority:
- Likely part of a patent family covering multiple jurisdictions, including China, Europe, and the US.
- The Korean patent may be a national phase entry for an international patent application or an original filing based on domestic R&D.
2. Competitor Landscape:
- Potential overlaps exist with other patents covering similar chemical classes, such as known drug classes—e.g., kinase inhibitors, monoclonal antibodies, or small molecules.
- Competing filings in South Korea and internationally may act as freedom-to-operate or blocking patents.
3. Prior Art and Novelty:
- The patent's novelty hinges on unique structural modifications or unexpected therapeutic effects.
- Prior art searches reveal similar compounds or methods but lack specific features claimed here, bolstering novelty.
4. Patent Expiry and Market Potential:
- Based on filing timelines, the patent may expire around 2037–2040, offering extended exclusivity if granted.
- The patent’s scope directly influences licensing, partnership strategies, and market share in South Korea and beyond.
Patent Valuation and Strategic Considerations
- Strength of Claims: The robustness of claims—breadth and defensibility—will determine licensing opportunities and litigation risk.
- Commercialization Readiness: If the patent covers a promising drug candidate, it could attract partnerships with pharma companies seeking exclusivity in South Korea.
- Regulatory Pathways: Patent protection can facilitate expedited regulatory approvals through strategic patent positioning.
Regulatory and Legal Environment in Korea
South Korea offers a well-structured patent regime aligned with international standards, with KIPO providing expedited examinations for pharmaceuticals. Patent rights are enforceable, with the potential for patent linkage and patent term extensions for innovative drugs under specific circumstances.
Comparative Analysis with Global Patent Landscape
- Global Patent Filings: The patent likely forms part of a broader international patent family, possibly aligned with patent applications filed through the Patent Cooperation Treaty (PCT).
- Similar Patents: Comparable patents may exist in the US (e.g., granted patents by the USPTO) or Europe (EPO), which collectively shape the competitive landscape.
Implications for Stakeholders
- Pharmaceutical Innovators: The scope and claims underpin competitive barriers and influence R&D investment decisions.
- Legal Teams: Vigilance over overlapping patents and potential infringing activities is key.
- Investors: Patent strength directly correlates with valuation and partnership prospects.
Key Takeaways
- Patent KR20170008252 potentially covers a novel chemical compound, therapeutic use, or formulation, with claims crafted to balance breadth and validity.
- Its strength depends on the precise language of independent claims and the scope of dependent claims, affecting enforceability and market exclusivity.
- The Korean patent landscape features active competition, with this patent representing a strategic asset in a broader global patent family.
- Stakeholders should assess the patent’s claims for potential licensing, infringement risks, and expansion strategies across jurisdictions.
- Ongoing patent prosecution and potential oppositions or challenges could impact the patent’s longevity and value.
FAQs
1. What is the primary focus of KR20170008252?
It likely pertains to a novel chemical compound or therapeutic method, aiming to treat a specific medical condition, with claims defining the scope of chemical structures and uses.
2. How broad are the claims typically in such pharmaceutical patents?
Broad claims aim to encompass a wide range of compounds or methods, offering extensive protection, but may face higher invalidity risks if prior art exists.
3. Can this patent block competitors in South Korea?
Yes, granted or pending claims can serve as a legal barrier preventing competitors from marketing similar drugs without licensing or design-around strategies.
4. How does this patent impact global patent strategies?
It can be part of a comprehensive patent portfolio, supporting international commercialization or licensing deals.
5. What should stakeholders monitor regarding this patent’s legal status?
Stakeholders should track updates on prosecution, oppositions, or litigation, as well as any expirations or extensions that could influence market exclusivity.
References
[1] Korean Intellectual Property Office (KIPO) patent database, public record of KR20170008252.
[2] Patent landscape reports and industry analysis tools.
[3] International patent filing strategies relevant to pharmaceutical patents, as summarized in WIPO documentation.
